Christina Y. Yim et al. also confirmed that G0S2 suppressed breast cancer by repressing a Myc-regulated transcriptional program which was known to favor tamoxifen resistance (Yim et al. 2016). This evidence concerns the gene G0S2 and breast carcinoma.